|
Market Closed -
Other stock markets
|
After hours 06:38:27 pm | |||
| 41.98 USD | -34.63% |
|
44.24 | +5.40% |
| Jun. 23 | Sector Update: Health Care Stocks Mixed Late Afternoon | MT |
| Jun. 23 | Novo, Hims & Hers engage in war of words after Wegovy deal falls apart | RE |
| Capitalization | 14.37B 12.42B 11.67B 10.63B 19.73B 1,241B 22.26B 138B 53.01B 569B 53.93B 52.78B 2,101B | P/E ratio 2025 * |
-
| P/E ratio 2026 * | - |
|---|---|---|---|---|---|
| Enterprise value | 13.81B 11.93B 11.21B 10.21B 18.95B 1,191B 21.38B 132B 50.91B 547B 51.79B 50.69B 2,018B | EV / Sales 2025 * |
-
| EV / Sales 2026 * | - |
| Free-Float |
84.41% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Hims & Hers Health, Inc.
More recommendations
More press releases
More news
| 1 day | +4.17% | ||
| 1 week | -24.33% | ||
| Current month | -25.78% | ||
| 1 month | -21.56% | ||
| 3 months | +20.81% | ||
| 6 months | +60.23% | ||
| Current year | +73.61% |
| 1 week | 41.97 |  | 64.6 |
| 1 month | 41.97 | | 67.37 |
| Current year | 23.97 | | 72.98 |
| 1 year | 13.47 | | 72.98 |
| 3 years | 4.01 | | 72.98 |
| 5 years | 2.72 | | 72.98 |
| 10 years | 2.72 | | 72.98 |
| Manager | Title | Age | Since |
|---|---|---|---|
Andrew Dudum
CEO | Chief Executive Officer | 36 | 2021-01-19 |
Oluyemi Okupe
DFI | Director of Finance/CFO | 39 | 2022-01-23 |
Nader Kabbani
COO | Chief Operating Officer | - | 2025-05-18 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrew Dudum
CHM | Chairman | 36 | 2021-01-19 |
Delos Cosgrove
BRD | Director/Board Member | 84 | 2021-01-19 |
David Wells
BRD | Director/Board Member | 53 | 2021-01-19 |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 0.02% | 311 M€ | +2.62% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -34.63% | -24.33% | +89.53% | +862.84% | 14.37B | ||
| +14.35% | +15.01% | -18.74% | -75.92% | 1.21B | ||
| -3.85% | -4.43% | +66.67% | +66.67% | 744M | ||
| +2.99% | -3.16% | +29.58% | +67.27% | 448M | ||
| -0.30% | -0.74% | -9.05% | -92.54% | 105M | ||
| Average | +1.26% | +1.99% | +31.59% | +165.66% | 3.38B | |
| Weighted average by Cap. | +3.69% | +13.29% | +78.55% | +733.34% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | - | - |
| Net income | 170M 147M 138M 126M 234M 14.7B 264M 1.63B 628M 6.75B 639M 625M 24.89B | 232M 200M 188M 171M 318M 20B 359M 2.22B 855M 9.18B 869M 851M 33.87B |
| Net Debt | -569M -491M -462M -421M -781M -49.1B -881M -5.46B -2.1B -22.54B -2.13B -2.09B -83.15B | -1.03B -892M -839M -764M -1.42B -89.14B -1.6B -9.91B -3.81B -40.91B -3.88B -3.79B -151B |
More financial data
* Estimated data
Employees
1,637
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-06-23 | 41.98 $ | -34.63% | 170,739,226 |
| 25-06-20 | 64.22 $ | +5.16% | 42,237,226 |
| 25-06-18 | 61.07 $ | +3.09% | 43,348,370 |
| 25-06-17 | 59.24 $ | -0.90% | 35,241,435 |
Delayed Quote Nyse, June 23, 2025 at 04:00 pm EDT
More quotes
Sell
Buy
Mean consensus
Number of Analysts
0
Last Close Price
41.98
Average target price
-
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- HIMS Stock
Select your edition
All financial news and data tailored to specific country editions
